Welcome to LookChem.com Sign In|Join Free
  • or
2-PROPYLNONANOIC ACID is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

65185-82-2

Post Buying Request

65185-82-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

65185-82-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 65185-82-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,5,1,8 and 5 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 65185-82:
(7*6)+(6*5)+(5*1)+(4*8)+(3*5)+(2*8)+(1*2)=142
142 % 10 = 2
So 65185-82-2 is a valid CAS Registry Number.
InChI:InChI=1/C12H24O2/c1-3-5-6-7-8-10-11(9-4-2)12(13)14/h11H,3-10H2,1-2H3,(H,13,14)

65185-82-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-PROPYLNONANOIC ACID

1.2 Other means of identification

Product number -
Other names 2-propyl-1-nonanoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:65185-82-2 SDS

65185-82-2Downstream Products

65185-82-2Relevant academic research and scientific papers

Use of branched chain fatty acids and derivatives thereof for inhibition of P-glycoprotein

-

, (2008/06/13)

The invention relates to the use of branched chain fatty acids (BFAs) and their derivatives for inhibition of the activity of P-glycoprotein (P-gp). In particular, the invention relates to the use of BFAs and their derivatives in the treatment of multi-drug resistant (MDR) tumors associated with increased activity of P-glycoprotein. The invention also relates to the use of the above-mentioned molecules for administration of biologically active molecules and diagnostic agents into cells associated with increased activity of P-gp, and for increasing accumulation of biologically active molecules and diagnostic agents in organs protected by biological barriers.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 65185-82-2